VNDA 8-K 2026-01-08

Vanda Pharmaceuticals Inc. (VNDA) 8-K dated 2026-01-08 — accession 0001628280-26-001273. This URL is the filing, not the VNDA hub.

Vanda Pharmaceuticals Inc. (VNDA) is a biotechnology company listed on NASDAQ.

Vanda Pharmaceuticals Inc. filed a 8-K on 2026-01-08. Accession 0001628280-26-001273.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported VNDA revenue for 2025-12-31 was $216.1M. Net income was -$220.5M. Revenue was up 8.7% from 2024-12-31 to 2025-12-31. VNDA currently screens at market cap $358.4M.

Not investment advice. The VNDA SEC hub lists recent forms. The stock page is the research view.